Skip to Main Content

Paper Details

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
EBioMedicine
205
2015
100 genes, AMACR, CNA, ELAC2, MAP3K7, MELK, MSMB, MYC, NKX3-1, NKX3-1, RB1 and PTEN deletions, PCA3, PSA, PTEN, RB1, RCBTB2, TPD52, ZBTB4, discriminating genes, eQTL, expression quantitative trait loci, gene sets, gene signatures, genomic loci, germline samples, mRNA, men, patient, patients, primary prostate cancer, prostate cancer, tumour
Author NameAffiliation
Helen J RossCancer Research UK Cambridge Institute, University of Cambridge
Alastair D LambCancer Research UK Cambridge Institute, University of Cambridge, Addenbrooke's Hospital
Mark J DunningCancer Research UK Cambridge Institute, University of Cambridge
Silvia HalimCancer Research UK Cambridge Institute, University of Cambridge
Johan LindbergKarolinska Institutet
Charlie E MassieCancer Research UK Cambridge Institute, University of Cambridge
Lars EgevadKarolinska Institutet
Jonathan KayCancer Research UK Cambridge Institute, University of Cambridge, University College London
Hayley C WhitakerCancer Research UK Cambridge Institute, University of Cambridge, University College London
Jeremy ClarkUniversity of East Anglia
Rachel HurstUniversity of East Anglia
Vincent J GnanapragasamAddenbrooke's Hospital, University of Cambridge
Nimish ShahAddenbrooke's Hospital
Anne Y WarrenAddenbrooke's Hospital
Colin S CooperUniversity of East Anglia
Andy G LynchCancer Research UK Cambridge Institute, University of Cambridge
Ian G MillsCancer Research UK Cambridge Institute, University of Cambridge, University of Oslo and Oslo University Hospital, Institute of Cancer Research, Oslo University Hospitals, Queen's University
Henrik Gr??nbergUniversity of Cambridge
Henrik Gr??nbergUniversity of Cambridge
David E NealCancer Research UK Cambridge Institute, University of Cambridge, Addenbrooke's Hospital
  • 1 - 20

Datasets